Release mechanisms behind polysaccharides-based famotidine controlled release matrix tablets

AAPS PharmSciTech

Volumn 9, Issue 4, 2008, Pages 1230-1239

  Elmowafy, Enas M ^a   Awad, Gehanne A S ^a   Mansour, Samar ^a   El Shamy, Abd El Hamid A ^a  

^a African Union Organization St Abbassia   (Egypt)

Author keywords

Cellulose ethers; Famotidine; Floating tablets; Polypropylene foam powder; Polysaccharides

Indexed keywords

CARBOXYMETHYLCELLULOSE; CARRAGEENAN; CELLULOSE; FAMOTIDINE; GELLAN; HYDROXYPROPYLCELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE; PECTIN; POLYPROPYLENE; POLYSACCHARIDE; UNCLASSIFIED DRUG; XYLOGLUCAN;

ARTICLE; CONTROLLED RELEASE FORMULATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG SOLUBILITY; FLOATING MATRIX TABLET; HYDROGEN BOND; INFRARED SPECTROSCOPY; MATRIX TABLET; PH; TABLET DISINTEGRATION; TABLET EROSION; TABLET FORMULATION; TABLET PROPERTY; TABLET SWELLING; THERMOSTABILITY; CHEMISTRY; DELAYED RELEASE FORMULATION; TABLET;

CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; FAMOTIDINE; POLYSACCHARIDES; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TABLETS;

EID: 63649106584     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-008-9155-4     Document Type: Article

References (38)

1. A. Bartkowiak, and D. Hunkeler. Carrageenan-oligochitosan microcapsules: optimization of the formation process. Colloids Surf. B Biointerfaces. 21:285-298 (2001).
2. K. M. Picker. Matrix tablets of carrageenans. II. Release behavior and effect of added cations. Drug Dev. Ind. Pharm. 25:339-346 (1999).
3. S. Miyazaki, N. Kawasaki, W. Kubo, K. Endo, and D. Attwood. Comparison of in situ gelling formulations for the oral delivery of cimetidine. Int. J. Pharm. 220:161-168 (2001).
4. K. Nishinari, K. Yamatoya, and M. Shirakawa. Xyloglucan. In G. O. Phillips, and P. A. Williams (eds.), Handbook of Hydrocolloids, CRC, Boca Raton, 2000, pp. 247-267.
5. C. Rolin. Pectin. In R. L. Whistler, and J. N. Bemiller (eds.), Industrial Gums: Polysaccharides and their Derivatives, Academic, New York, NY, 1993, pp. 257-293.
6. J. Nerurkar, H. W. Jun, J. C. Price, and M. O. Park. Controlled-release matrix tablets of ibuprofen using cellulose ethers and carrageenans: effect of formulation factors on dissolution rates. Eur. J. Pharm. Biopharm. 61:56-68 (2005).
7. S. Sungthongjeen, T. Pitaksuteepong, A. Somsiri, and P. Sriamornsak. Studies on pectins as potential hydrogel matrices for controlled-release drug delivery. Drug Dev. Ind. Pharm. 25:1271-1276 (1999).
8. Y. D. Sanzgiri, S. Maschi, V. Crescenzi, L. Callegaro, E. M. Topp, and V. J. Stella. Gellan-based systems for ophthalmic sustained delivery of methylprednisolone. J. Control. Release. 26:195-201 (1993).
9. S. A. Agnihorti, S. S. Jawalkar, and T. M. Aminabhavi. Controlled release of cephalexin through gellan gum beads: Effect of formulation parameters on entrapment efficiency, size, and drug release. Eur. J. Pharm. Biopharm. 63:249-261 (2006).
10. P. S. Rajinikanth, J. Balasubramaniam, and B. Mistral. Development and evaluation of a novel floating in situ gelling system of amoxicillin for eradication of Helicobacter pylori. Int. J. Pharm. 335:114-122 (2006).
11. S. Miyazaki, F. Suisha, N. Kawasaki, M. Shirakawa, K. Yamatoya, and D. Attwood. Thermally reversible xyloglucan gels as vehicles for rectal drug delivery. J. Control Release. 56:75-83 (1998).
12. F. Suisha, N. Kawasaki, S. Miyazaki, M. Shirakawa, K. Yamatoya, M. Sasaki, and D. Attwood. Xyloglucan gels as sustained release vehicles for the intraperitoneal administration of mitomycin C. Int. J. Pharm. 172:27-32 (1998).
13. N. Kawasaki, R. Ohkura, S. Miyazaki, Y. Uno, S. Sugimoto, and D. Attwood. Thermally reversible xyloglucan gels as vehicles for oral drug delivery. Int J Pharm. 181:227-234 (1999).
14. C. Dollery. In: Therapeutic Drugs, volume I, 2nd edition, Churchill Livingstone, Edinburgh London New York Philadelphia San Francisco Sydney Toranto; 1999.
15. B. Mehta, M. M. Doshi, M. D. Joshi. Floating osmotic device for controlled release drug delivery. US Patent. 2003;20030064101.
16. 2-antagonists. Biochem. Pharmacol. 48:229 (1994).
17. J. T. Fell, L. Whitehead, and J. H. Collet. Prolonged gastric retention using floating dosage forms. Pharm. Technol. 24(3):82-87 (2000).
18. L. Illum, and P. He. Gastroretentive controlled release microspheres for improved drug delivery. US Patent 2001;6,207,197.
19. P. Dettmar, P. A. Dickson, F. C. Hampson, I. G. Jollife, and W. Peers. Mucoadhesive granules of carbomer suitable for oral administration of drugs. US Patent 2001; 6, 306,789.
20. M. Jaimini, A. C. Rana, and Y. S. Tanwar. Formulation and evaluation of famotidine floating tablets. Current Drug Delivery. 4(1):51-55 (2007).
21. A. Streubel, J. Siepmann, and R. Bodmeier. Floating matrix tablets based on low density foam powder: Effects of formulation and processing parameters on drug release. Eur. J. Pharm. Sci. 18:37-45 (2003).
22. P. L. Bardonnet, V. Faivre, W. J. Pugh, J. C. Piffaretti, and F. Falson. Gastroretentive dosage forms: Overview and special case of Helicobacter pylori. J. Control Release. 111:1-18 (2006).
23. M. Rosa, H. Zia, and T. Rhodes. Dosing and testing in-vitro of a bioadhesive and floating drug delivery system for oral application. Int. J. Pharm. 105:65-70 (1994).
24. P. L. Ritger, and N. A. Peppas. A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J. Control Release. 5:37-42 (1987).
25. L. Vachoud, N. Zydowicz, and A. Domard. Physicochemical behavior of chitin gels. Carbohydr. Res. 326:295-304 (2000).
26. B. Saša, P. Odon, S. Stane, and K. Julijana. Analysis of surface properties of cellulose ethers and drug release from their matrix tablets. Eur. J. Pharm. Sci. 27:375-383 (2006).
27. D. A. Alderman. A review of cellulose ethers in hydrophilic matrices for oral controlled-release dosage forms. Int. J. Pharm. 5(3):1-9 (1984).
28. J. Timmermans, and A. J. Moes. The cutoff size for gastric emptying of dosage forms. J. Pharm. Sci. 828:854 (1993).
29. G. Chawla, P. Gupta, V. Koradia, and A. K. Bansal. Gastroretention: A means to address regional variability in intestinal drug absorption. Pharm. Tech. 27:50-68 (2003).
30. P. Sher, G. Ingavle, S. Ponrathnam, and A. P. Pawar. Low density porous carrier: Drug adsorption and release study by response surface methodology using different solvents. Int. J. Pharm. 331:72-83 (2007).
31. T. W. Wong, H. Y. Lee, L. W. Chan, and P. W. S. Heng. Drug release properties of pectinate microspheres prepared by emulsification method. Int J Pharm. 242:233-237 (2002).
32. Y. Pranoto, C. M. Lee, and H. J. Park. Characterizations of fish gelatin films added with gellan and κ-carrageenan. LWT. 40:766-774 (2007).
33. A. S. Hussain, R. D. Johnson, P. Shivanand, and M. A. Zoglio. Effects of blending a nonionic and an anionic cellulose ether polymer on drug release from hydrophilic matrix capsules. Drug Dev. Ind. Pharm. 20(17):2645-2657 (1994).
34. M. G. Sankalia, R. C. Mashru, J. M. Sankalia, and V. B. Sutariya. Stability improvement of alpha-amylase entrapped in kappa-carrageenan beads: Physicochemical characterization and optimization using composite index. Int. J. Pharm. 312:1-14 (2006).
35. A. R. Menjoge, and M. G. Kulkarni. Mechanistic investigations of phase behavior in Eudragit® E blends. Int. J. Pharm. 343:106-121 (2007).
36. B. N. Singh, and K. H. Kim. Characterization and relevance of physicochemical interactions among components of a novel multiparticulate formulation for colonic delivery. Int. J. Pharm. 341:143-151 (2007).
37. K. S. Bhise, R. S. Dhumal, B. Chauhan, A. Paradkar, and S. S. Kadam. Effect of oppositely charged polymer and dissolution medium on swelling, erosion, and drug release from chitosan matrices. AAPS PharmSciTech. 2007 8(2):aRticle 44(E1-E9).
38. B. Hegedus, P. Bod, K. Harsanyi, I. Peter, A. Kalman, and L. Parkanyi. Comparison of the polymorphic modifications of famotidine. J. Pharma. Biomed. Anal. 7:563 (1989).